Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway

Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), has been demonstrated to alleviate non-alcoholic fatty liver disease (NAFLD). However, the underlying mechanism has not been fully elucidated. Increasing evidence suggests that autophagy is involved in the pathogenesis of hepatic ste...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yunyun, Ji, Linlin, Zhu, Chaoyu, Xiao, Yuanyuan, Zhang, Jingjing, Lu, Junxi, Yin, Jun, Wei, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729067/
https://www.ncbi.nlm.nih.gov/pubmed/33330497
http://dx.doi.org/10.3389/fcell.2020.602574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729067/
https://www.ncbi.nlm.nih.gov/pubmed/33330497
http://dx.doi.org/10.3389/fcell.2020.602574

Ejemplares similares